[1] 周爱国, 候俊, 冯鑫,等. 酒精性肝病与非酒精性脂肪肝患者血清GP73水平差异及意义. 中华实验和临床病毒学杂志, 2017, 31:162.
[2] 杨小花, 吴时胜, 刘斌,等. 还原型谷胱甘肽联合丹参注射液治疗酒精性肝病失代偿期肝硬化患者的临床观察. 中国中医急症, 2017, 26:671-673.
[3] Atkinson S R, Way M J, Mcquillin A, et al. Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis. J Hepatol, 2017, 67:S016882781730051X.
[4] Atkinson S, Way M, Mcquillin A, et al. PWE-079 Drinking behaviour and rs738409:g in pnpla3 are associated with slower recovery of liver function following severe alcoholic hepatitis. J Hepatol, 2017, 66:S116-S117.
[5] 李银玲, 王炳元. 酒精依赖和酒精相关性肝病的遗传学研究进展. 肝脏, 2017, 22:392-394.
[6] 杨馥宁, 黄晶. 酒精性肝病的遗传易感性研究现状. 临床肝胆病杂志, 2017, 33:379-383.
[7] 眭维国, 甘晴, 杨明,等. 酒精性肝硬化相关原发性肝癌患者外周血环状RNA差异表达研究. 中华肿瘤防治杂志, 2017, 24:1451-1455.
[8] 魏益国, 陈捷, 石明巧,等. PNPLA3基因多态性与非酒精性脂肪性肝病肝损伤间相关性的系统评价. 检验医学与临床, 2018, 15:157-160.
[9] Chandak SV, Amarapurkar D, Parekh S, et al. Patatin-like phospholipase domain-containing protein 3(PNPLA3) gene polymorphism has a significantly stronger association in diabetics with advanced liver disease as compared to diabetics without liver disease. Gastroenterology, 2017, 152:S1205-S1206.
[10] 徐贝贝, 李银玲, 王炳元. 酒精性肝病相关危险因素的研究进展. 中华肝脏病杂志, 2017, 25:397. |
